Prestige Consumer Healthcare PBH Business Segments
| Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | ||
|---|---|---|---|---|---|---|
| Total revenues by Business | ||||||
| International OTC Healthcare | $47.07M-1.4% | $47.75M+10.1% | $43.36M+17.3% | $36.95M-22.3% | $47.57M-7.4% | |
| North American OTC Healthcare | $234.55M-0.5% | $235.7M+2.1% | $230.76M+8.6% | $212.58M-14.6% | $248.95M+4.2% | |
| Total revenues by Product | ||||||
| Analgesics | $28.24M+0.7% | $28.03M-2.4% | $28.73M-0.7% | $28.93M-4.2% | $30.2M-2.5% | |
| Cough & Cold | $26.29M-10.4% | $29.33M+7.5% | $27.29M+43.6% | $19.01M-29.4% | $26.91M-8.3% | |
| Dermatologicals | $30.49M+2.9% | $29.64M-17.0% | $35.7M+18.6% | $30.11M+3.5% | $29.08M-5.1% | |
| Eye & Ear Care | $37.85M-1.9% | $38.6M+12.9% | $34.18M+5.8% | $32.31M-30.9% | $46.73M+2.3% | |
| Gastrointestinal | $68.35M-1.6% | $69.45M+8.2% | $64.2M+11.1% | $57.78M-16.1% | $68.88M-0.2% | |
| Oral Care | $28M+5.3% | $26.58M+7.3% | $24.77M+14.1% | $21.7M-19.9% | $27.09M+17.4% | |
| Other OTC | $5.35M+32.4% | $4.04M+32.1% | $3.06M+4.4% | $2.93M-23.8% | $3.85M+10.6% | |
| Women's Health | $57.05M-1.2% | $57.77M+2.8% | $56.2M-1.0% | $56.76M-11.0% | $63.78M+9.7% | |
| Percentage of deposits held in one location (as percent) by Geography | ||||||
| Singapore | 4%— | —— | —— | —— | 1%— | |
| Sydney, Australia | 18%— | —— | —— | —— | 11%— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Prestige Consumer Healthcare break its business down?
- Prestige Consumer Healthcare (PBH) reports total revenues by business across 2 parts — International OTC Healthcare and North American OTC Healthcare. Each is extracted from the segment footnotes and tracked over time.
- Where does Prestige Consumer Healthcare's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Prestige Consumer Healthcare's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
